|
|
|
|
|
|
It's National Immunization Awareness Month
|
|
|
If you have chronic lung disease, you may be at higher risk
for severe illness from infectious respiratory diseases. Are you up
to date on your vaccinations?
|
|
|
|
|
|
|
Pneumococcal Pneumonia
|
|
|
Did you know pneumococcal pneumonia is the
most common type of bacterial pneumonia and causes an estimated
150,000 hospitalizations each year in the U.S.? Pneumococcal
pneumonia can strike anytime, anywhere, in any season.
Pneumococcal pneumonia vaccines are available year-round to help
prevent the disease.
|
|
|
|
Pneumococcal pneumonia vaccination is
recommended for adults aged 19-64 with certain underlying medical
conditions such as asthma, COPD, and heart disease and all adults
aged 65 or older. Now is a good time to talk to a healthcare
provider about pneumococcal vaccination.
|
|
|
|
|
|
|
|
The American Lung Association and Pfizer
are partnering to share important facts about pneumococcal pneumonia.
|
|
|
|
|
|
|
|
Pertussis
|
|
|
Pertussis, or whooping cough, is a serious
respiratory illness that is easily spread from person to person.
Pertussis can lead to severe, sometimes life-threatening health
problems such as exacerbation of chronic medical conditions –
including asthma and COPD. The best way to help protect against
pertussis is by getting vaccinated. A vaccine called Tdap helps
protect against tetanus, diphtheria and pertussis and has been
used since 2005. If you are living with asthma or COPD, it’s
important to speak with your healthcare provider about getting a
vaccination to protect against pertussis.
|
|
|
|
|
|
|
|
The American Lung Association and Sanofi
work in collaboration to educate adults about the potential
dangers of pertussis.
|
|
|
|
|
|
|
|
COVID-19
|
|
|
COVID-19 vaccinations are now recommended
to everyone 6 months or older and are the best way to protect
your children, family, friends and community from severe COVID-19
illness.
|
|
|
|
Curious about the evolving questions
surrounding the COVID-19 vaccine?
We have answers.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No comments:
Post a Comment